Both in Diagnostics
VolitionRx Limited vs Immucell
Over the past year VNRX returned −97.9% and ICCC returned +72.4%; their daily moves had a correlation of -0.03.
VNRX −97.9% ICCC +72.4%Growth of $1, one year, split-adjusted
| Metric | VNRX | ICCC |
|---|---|---|
| Price | $0.1818 | $10.62 |
| Market cap | $5.5M | $96.5M |
| Today | −1.73% | +3.51% |
| 1 month | −29.0% | +6.8% |
| 6 months | −93.1% | +25.8% |
| Year to date | −96.4% | +72.7% |
| 1 year | −97.9% | +70.2% |
| Revenue growth (YoY) | −2.0% | +11.5% |
| Gross margin | 100.0% | 33.9% |
| Net margin | −1953.1% | 25.5% |
| P/E (TTM) | — | 122.5× |
| Price / sales | 2.2× | 3.1× |
| Net cash | -$8.3M | $557.3K |
| Dividend yield | — | — |
| Volatility (60d) | 113.6% | 37.8% |
| Short % of float | 5.1% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).